Article
T cell metabolic insufficiency explains the dysfunctional immune response in advanced renal cell carcinoma.
2022-12-01
Abstract excerpt
Renal cell carcinoma (RCC) is considered an immunogenic tumour with a prominent dysfunctional immune cell infiltrate, unable to control tumour growth. Although tyrosine kinase inhibitors and immunotherapy have improved the outlook for some patients, many individuals are non-responders or relapse despite treatment, and then develop progressive disease, cancer symptoms and will have a reduced life expectancy. Follow...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 79f34a40-5f1f-5297-a05e-cf696a2c1a8f
- DOI
- 10.21203/rs.3.rs-2320506/v1
